The Complete Prior Authorization Guide for GLP-1 Drugs

What Is Prior Authorization?

Prior authorization (PA), also called pre-authorization or pre-approval, is a requirement set by health insurance plans that mandates a prescriber obtain approval from the insurer before a specific medication or service will be covered. It is essentially the insurer's way of verifying that a treatment meets their coverage criteria before they agree to pay for it. For many medications, a PA is a routine administrative step. For GLP-1 medications, it is a more involved process that often requires significant clinical documentation.

The PA process exists for a combination of stated and unstated reasons. Officially, insurers say it ensures medications are used appropriately and that less expensive alternatives are tried first. In practice, it also functions as a cost-control mechanism. Because GLP-1 medications carry list prices well above $1,000 per month, insurers have strong financial incentives to require PA and to set the bar for approval high enough to limit how many members receive coverage. Understanding this dynamic is important because it means you may need to advocate persistently even when you clearly meet the medical criteria.

If your pharmacy tells you that your GLP-1 medication requires PA, do not assume this means you will not be covered. It simply means the process has not been completed yet. Many patients who initially receive PA rejections ultimately succeed in obtaining coverage after providing additional documentation or filing an appeal. The prior authorization process rewards preparation and persistence.

Why GLP-1 Medications Require Prior Auth

GLP-1 medications are subject to PA requirements at an exceptionally high rate compared to other drug classes. According to surveys of patients and pharmacists, nearly all commercial insurance plans that cover these drugs require prior authorization for at least some members. This is primarily driven by the cost: at retail prices of $1,000–$1,400 per month, a plan covering even a modest percentage of its members on GLP-1 therapy would face substantial financial exposure without controls in place.

A secondary driver is the overlapping indication landscape. Because several GLP-1 drugs share the same active ingredient but are approved for different conditions (for example, Ozempic for diabetes and Wegovy for obesity both contain semaglutide), insurers use PA as a gatekeeping mechanism to ensure members are using the formulation and dose approved for their covered indication. If your plan covers diabetes drugs but excludes weight loss drugs, a PA denial may be triggered simply by how the prescription was written rather than by a lack of medical necessity.

Step therapy requirements—sometimes called “fail first” policies—are another common feature of GLP-1 PA criteria. Under step therapy, your plan may require you to document that you have previously tried and failed to achieve adequate results with older, less expensive weight management medications or interventions before the plan will authorize a GLP-1. Knowing whether your plan has a step therapy requirement before you submit your PA request allows your doctor to include the necessary documentation upfront rather than having to resubmit after an initial denial.

Step 1: Get the Criteria from Your Insurer

The single most important thing you can do before initiating a PA request is to obtain the exact prior authorization criteria your insurer uses for the specific drug your doctor is prescribing. Do not guess or assume that generic GLP-1 criteria apply to your plan—criteria vary widely between insurers and even between plan types offered by the same insurer.

Call the member services number on the back of your insurance card and ask specifically: “Can you provide me with the prior authorization criteria for [drug name and NDC or drug code] under my plan?” Request that the criteria be sent to you by email or mail in writing. You can also ask your pharmacy to run a test claim and provide you with the PA codes returned, which will tell you which specific criteria set your plan is applying. Additionally, your doctor's office will often have access to real-time formulary and PA tools through the electronic health record system—ask them to pull up the criteria directly.

Once you have the criteria document, read it carefully and identify every requirement. Make a checklist. Common criteria elements include: minimum BMI, presence of at least one weight-related comorbidity, documentation of a supervised diet and exercise program, documentation of a previous trial of an alternative anti-obesity medication, a requirement for prescriber specialty (e.g., prescribed by or in consultation with a physician specializing in obesity medicine or endocrinology), and a requirement that the member be enrolled in a behavioral program. Knowing every criterion in advance lets you address them all in the initial submission.

Step 2: Gather Your Documentation

Once you have the criteria, begin assembling the documentation needed to satisfy each one. For BMI and weight history, your doctor's notes from recent visits should include your current weight and height. If you have been overweight for many years, historical weight data from past visits strengthens the case that this is a chronic condition requiring medical management rather than a short-term situation that could resolve without medication.

For comorbidities, gather documentation of all diagnosed conditions that qualify as weight-related: type 2 diabetes or prediabetes, hypertension, hyperlipidemia, obstructive sleep apnea, GERD, non-alcoholic fatty liver disease, osteoarthritis of weight-bearing joints, and cardiovascular disease are among the most commonly recognized by insurers. Lab results, specialist notes, and prescription records all serve as supporting evidence. Ask your doctor to include relevant lab values (HbA1c, fasting glucose, lipid panel, blood pressure readings) in the PA documentation.

If your plan requires documentation of prior lifestyle interventions or prior medications, compile a clear timeline. Include the name of any dietary programs you participated in (Weight Watchers, medically supervised low-calorie diets, structured exercise programs), approximate dates of participation, results achieved, and why the intervention was ultimately unsuccessful for long-term weight management. If you previously tried an older weight loss medication such as phentermine/topiramate, bupropion/naltrexone, or orlistat, document the drug name, dosage, duration of use, and outcome.

Organize all documentation clearly, with a cover page referencing the PA criteria and indicating where in the attached documents each criterion is addressed. This approach makes the reviewer's job easier and reduces the chance of a denial based on “missing information” that is actually present but difficult to locate.

Step 3: Work With Your Prescriber

Although the PA submission is technically the responsibility of the prescribing physician's office, the outcome depends heavily on the quality and completeness of the clinical information provided. Schedule a dedicated appointment or phone call with your doctor specifically to discuss the PA process. Bring your printed copy of the insurer's criteria and your documentation checklist, and go through each item together.

Ask your doctor to write a detailed letter of medical necessity that explicitly addresses every criterion on your insurer's list. The letter should state your diagnoses, your BMI, your relevant comorbidities, your prior treatment history, and a clear clinical rationale for why this specific GLP-1 medication is the appropriate next step in your treatment. The letter should also cite relevant clinical guidelines, such as the American Association of Clinical Endocrinologists (AACE) guidelines on obesity management or the American Heart Association/American College of Cardiology/The Obesity Society (AHA/ACC/TOS) guidelines, which endorse GLP-1 therapy for patients meeting specific criteria.

If your primary care physician is not familiar with writing PA letters for GLP-1 medications, they may be receptive to a referral to or consultation with an obesity medicine specialist. Board- certified obesity medicine physicians and endocrinologists routinely handle GLP-1 PAs and often have established workflows, template letters, and staff dedicated to navigating insurance requirements. A specialist consultation can also strengthen your case by providing additional clinical justification in the event of a denial and subsequent appeal.

Step 4: Submit and Follow Up

Once your documentation is assembled, your doctor's office will submit the PA request, typically by fax, through an online portal, or via your insurer's electronic PA platform (such as CoverMyMeds or Surescripts). Confirm with the office that the submission has been sent and ask for a confirmation number or submission reference. Write this down along with the date of submission.

Federal rules require non-urgent PA decisions within 72 hours of receiving all necessary information, and many states have enacted additional timelines. If you have not heard back within 3–5 business days, contact both your doctor's office and your insurer's member services line to check the status. Ask specifically whether the insurer has received all required documentation and whether the file is complete. Missing or incomplete information is one of the most common reasons for delays and for initial denials that could have been avoided.

If the insurer requests additional information, respond as quickly as possible. Every day of delay extends the time you are without medication. Ask the insurer's PA department to confirm exactly what additional information is needed, in writing, so that neither you nor your doctor's office has to guess. Once you supply the additional information, restart your tracking clock and follow up again within 3 business days.

What to Do If You're Denied

A PA denial is not the end of the road. You have the legal right to appeal any coverage denial, and many PA denials are overturned on appeal when the correct supporting documentation is provided. When you receive a denial, read the denial letter carefully. It must state the specific reason for the denial and the criteria that were not met. This information is the roadmap for your appeal.

For an expedited appeal (when a delay would seriously jeopardize your health), the insurer must respond within 72 hours. For a standard internal appeal, the timeframe is typically 30 days for non-urgent situations. Your denial letter will specify the deadline for filing your appeal, which is generally 180 days from the date of denial. File as early as possible—do not wait until the deadline is imminent.

Your appeal should include a formal appeal letter addressing each denial reason, an updated letter of medical necessity from your doctor, any additional clinical records that support your case, and references to peer-reviewed studies supporting the use of the medication for your condition. If your internal appeal is denied, you are entitled to an external independent review by a third party. External appeals have significant overturn rates for GLP-1 medications when properly documented. For a detailed walkthrough of the full appeals process, see our guide on how to get your insurance to cover GLP-1 medications.

While your appeal is pending, ask your doctor whether a peer-to- peer review is available. This is a phone call between your prescribing physician and the insurer's medical reviewer, conducted before or after a denial decision. Studies show that peer-to-peer reviews overturn PA denials at meaningful rates, particularly when the prescriber is well-prepared and can speak directly to the clinical criteria. Ask your doctor's office to request a peer-to-peer review if the initial PA is denied.

Keeping Your Authorization Active

Once your PA is approved, the authorization is not permanent. Most GLP-1 prior authorizations are valid for 6–12 months and must be renewed before the expiration date for coverage to continue. Mark your renewal date on your calendar as soon as you receive your approval letter, and set a reminder for 60 days before expiration to begin the renewal process. Do not wait until the last week before expiration, as processing delays could result in a gap in coverage.

Renewal PA criteria may include evidence that you are responding to the medication. Some plans require documentation that you have lost a minimum percentage of your body weight during the initial authorization period (commonly 5% at 12 weeks or 5–10% over the full authorization period) in order to renew coverage. Ask your insurer about renewal criteria upfront so that you and your doctor can track the relevant metrics throughout the year and ensure the renewal documentation is strong.

Keep copies of all PA approvals, denial letters, and appeal decisions in a dedicated folder, either physical or digital. If you change insurance plans—which commonly happens during annual open enrollment or if you change employers—you will need to restart the PA process under your new plan. Having your prior documentation readily accessible will make this process faster. Be aware that a PA approval under one insurer does not transfer to a different insurer; each plan evaluates your request independently under its own criteria.